Scarica l'app Stockscreener
10.04
1.93%
0.19
Immix Biopharma Inc Azioni (IMMX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
14.06%
7.6625
|
6.7177 | 4.6829 | 4.9871 | 7.3949 |
| Operating Income/Loss |
14.06%
-7.6625
|
-6.7177 | -4.6829 | -4.9871 | -7.3949 |
| Nonoperating Income/Loss |
18.76%
0.0845
|
0.1041 | 0.1502 | 0.1859 | 0.2567 |
| Income/Loss From Continuing Operations Before Tax |
14.58%
-7.578
|
-6.6136 | -4.5327 | -4.8013 | -7.1383 |
| Income Tax Expense/Benefit |
13.37%
0.00772
|
0.00891 | 0.00982 | 0.0108 | 0.0111 |
| Income/Loss From Continuing Operations After Tax |
14.54%
-7.5857
|
-6.6226 | -4.5425 | -4.8121 | -7.1494 |
|
Net Income/Loss
|
14.54%
-7.5857
|
-6.6226 | -4.5425 | -4.8121 | -7.1494 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
6.48%
31.93
|
29.98 | 29.70 | 0.4261 | 29.42 |
| Diluted Average Shares |
6.48%
31.93
|
29.98 | 29.70 | 0.4261 | 29.42 |
| Basic Earnings Per Share |
9.09%
-0.24
|
-0.22 | -0.15 | -0.16 | -0.24 |
| Diluted Earnings Per Share |
9.09%
-0.24
|
-0.22 | -0.15 | -0.16 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):